Lymphoma survivors with chronic fatigue participating in a multidisciplinary intervention program experienced a beneficial ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...

Blood cancers such as leukemia, lymphoma, and myeloma often begin in the bone marrow and disrupt normal blood cell formation.

CAR2119’s single-infusion approach offers cost and compliance advantages, though its competitors maintain strong commercial ...

Jeremy S Abramson and colleagues reported that glofitamab plus gemcitabine and oxaliplatin (GemOx) significantly improved overall survival (OS) in transplant-ineligible patients with relapsed or ...

The indolent lymphoma market is witnessing steady growth driven by the increasing prevalence of slow-growing non-Hodgkin ...

Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...

MUSCAT: The University Medical City (UMC) launched the Bone Marrow Transplant Unit as part of the National Haematology and ...

MUSCAT: The University Medical City (UMC) launched the Bone Marrow Transplant Unit as part of the National Hematology and ...

A bone marrow transplant can help people diagnosed with leukemia and other serious bone marrow–related conditions.

The event will provide clinical perspectives and market outlook for lacutamab, Innate’s lead proprietary product progressing ...